|
|
|
|
64 * !
|
Mon, 8/9/2021,
10:00 AM -
11:50 AM
|
Virtual
|
|
Innovative Practical Improvements in Biomarker Development and Evaluation — Invited Papers
|
|
Section on Medical Devices and Diagnostics, Biometrics Section, Biopharmaceutical Section, Caucus for Women in Statistics
|
|
Organizer(s): Laura Yee, National Cancer Institute, National Institutes of Health
|
|
Chair(s): Hari Sankaran, National Cancer Institute, National Institutes of Health
|
|
10:05 AM
|
Emulating a Target Trial to Evaluate the Clinical Utility of a Biomarker-Based Treatment Rule
Michael Charles Sachs, Karolinska Institutet
|
|
10:25 AM
|
Two-Stage Adaptive Design for Prognostic Biomarker Signatures with a Survival Endpoint
Mei-Yin C Polley, University of Chicago; Biyue Dai, University of Iowa
|
|
10:45 AM
|
Biologically Informed Development of Treatment Selection Scores from High-Dimensional Omics Data
Lisa McShane, National Cancer Institute
|
|
11:05 AM
|
Sample Size Methods for Validation of Predictive Biomarkers
Kevin K Dobbin, University of Georgia; Lisa McShane, National Cancer Institute
|
|
11:25 AM
|
Discussant: Ana Best, National Cancer Institute, National Institutes of Health
|
|
11:45 AM
|
Floor Discussion
|
